U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07377487) titled 'TheraSphere Japan Pre-Market Study' on Sept. 24, 2025.
Brief Summary: To investigate the safety and effectiveness of BSJ019T in Japanese patients with primary or secondary liver who are not candidate for standard treatment.
Study Start Date: Jan. 22
Study Type: INTERVENTIONAL
Condition:
Liver Neoplasms
Intervention:
DEVICE: TheraSphere Y-90 glass microsphere
TheraSphere Y-90 glass microsphere therapy administered through the hepatic artery at index procedure.
Recruitment Status: RECRUITING
Sponsor: Boston Scientific Corporation
Disclaimer: Curated by HT Syndication....